TITLE

48 hours of cisatracurium reduced 90-day mortality in patients with early, severe ARDS

AUTHOR(S)
Sevransky, Jonathan
PUB. DATE
January 2011
SOURCE
ACP Journal Club;1/18/2011, Vol. 154 Issue 1, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on a study which has revealed that short-term treatment with cisatracurium besylate, a neuromuscular-blocking agent, reduced 90-day mortality in patients with early, severe acute respiratory distress syndrome (ARDS). It has also been suggested by the study that in a subset of patients with ARDS, it may be reasonable to use a short-term infusion of cisatracurium in conjunction with deep sedation and volume- and pressure-limited ventilation.
ACCESSION #
65456970

 

Related Articles

  • 2010 ->48 hours of cisatracurium reduced 90-day mortality in patients with early, severe ARDS. Sevransky, Jonathan // ACP Journal Club;1/18/2011, Vol. 154 Issue 1, p2 

    Question: In patients with early, severe acute respiratory distress syndrome (ARDS), does short-term treatment with cisatracurium besylate, a neuromuscular-blocking agent, improve clinical outcomes? Methods Design Randomized placebo-controlled trial (ARDS et Curarisation Systematique [ACURASYS]...

  • Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Alhazzani, Waleed; Alshahrani, Mohamed; Jaeschke, Roman; Forel, Jean Marie; Papazian, Laurent; Sevransky, Jonathan; Meade, Maureen O. // Critical Care;2013, Vol. 17 Issue 2, Special section p1 

    Introduction: Randomized trials investigating neuromuscular blocking agents in adult acute respiratory distress syndrome (ARDS) have been inconclusive about effects on mortality, which is very high in this population. Uncertainty also exists about the associated risk of ICU-acquired weakness....

  • Neuromuscular Blockers and ARDS. Devlin, John W.; Garpestad, Erik; Hill, Nicholas S. // New England Journal of Medicine;12/23/2010, Vol. 363 Issue 26, p2562 

    A letter to the editor is presented in response to an article about patients with acute respiratory distress syndrome (ARDS) treated early with cisatracurium, in the September 16, 2010 issue.

  • β-agonists found to increase mortality in early ARDS.  // Reactions Weekly;12/17/2011, Issue 1382, p1 

    The article focuses on the findings from the BALTI-2 trial that salbutamol increase mortality in patients with early acute respiratory distress syndrome (ARDS). The patients involved in the study were chosen from several intensive care units (ICUs) in Great Britain and were receiving intravenous...

  • Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Forel, Jean-Marie; Voillet, François; Pulina, Daniel; Gacouin, Arnaud; Perrin, Gilles; Barrau, Karine; Jaber, Samir; Arnal, Jean-Michel; Fathallah, Mohamed; Auquier, Pascal; Roch, Antoine; Azoulay, Elie; Papazian, Laurent // Critical Care;2012, Vol. 16 Issue 1, pR65 

    Introduction: Ventilator-associated pneumonia (VAP) may contribute to the mortality associated with acute respiratory distress syndrome (ARDS). We aimed to determine the incidence, outcome, and risk factors of bacterial VAP complicating severe ARDS in patients ventilated by using a...

  • Lower tidal volume at initiation of mechanical ventilation may reduce progression to acute respiratory distress syndrome: a systematic review. Fuller, Brian M.; Mohr, Nicholas M.; Drewry, Anne M.; Carpenter, Christopher R. // Critical Care;2013, Vol. 17 Issue 1, p1 

    Introduction: The most appropriate tidal volume in patients without acute respiratory distress syndrome (ARDS) is controversial and has not been rigorously examined. Our objective was to determine whether a mechanical ventilation strategy using lower tidal volume is associated with a decreased...

  • Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses. Tonelli, Adriano; Zein, Joe; Adams, Jacob; Ioannidis, John // Intensive Care Medicine;Jun2014, Vol. 40 Issue 6, p769 

    Purpose: Multiple interventions have been tested in acute respiratory distress syndrome (ARDS). We examined the entire agenda of published randomized controlled trials (RCTs) in ARDS that reported on mortality and of respective meta-analyses. Methods: We searched PubMed, the Cochrane Library,...

  • A Comprehensive Review of Prone Position in ARDS. Kallet, Richard H. // Respiratory Care;Nov2015, Vol. 60 Issue 11, p1660 

    Prone position (PP) has been used since the 1970s to treat severe hypoxemia in patients with ARDS because of its effectiveness at improving gas exchange. Compared with the supine position (SP), placing patients in PP effects a more even tidal volume distribution, in part, by reversing the...

  • Prone positioning for 16 h/d reduced mortality more than supine positioning in early severe ARDS. Thompson, B. Taylor // ACP Journal Club;9/17/2013, Vol. 159 Issue 6, p1 

    Question In adults with severe acute respiratory distress syndrome (ARDS), what is the efficacy of early prone positioning compared with supine positioning? Methods Design Randomized controlled trial (Proning Severe ARDS Patients [PROSEVA] study). ClinicalTrials.gov NCT00527813. Allocation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics